期刊文献+

抗环瓜氨酸肽抗体与系统性红斑狼疮伴发关节炎的相关性研究 被引量:3

Clinical significance of anti-cyclic citrullinate peptides antibody in systemic lupus erythematosus
暂未订购
导出
摘要 目的研究抗环瓜氨酸肽(CCP)抗体在系统性红斑狼疮(SLE)患者中的临床意义,探讨抗CCP抗体与SLE患者伴发关节炎、骨侵蚀破坏的关系及判断预后的意义。方法采用酶联免疫吸附试验(ELISA)法和速率比浊法检测145例SLE患者血清中抗CCP抗体和IgM-RF。结果抗CCP抗体在SLE患者中的阳性率为24.1%。抗CCP抗体阳性的SLE患者关节炎的发生率明显高于抗CCP抗体阴性者(77.1%与38.2%,P<0.05)。SLE伴发关节炎组抗CCP抗体阳性率(39.1%)高于非关节炎组(10.5%)(P<0.05);抗CCP抗体阳性组RF阳性率(38.5%)高于抗CCP抗体阴性组(24.4%)(P<0.05)。抗CCP抗体阳性患者较阴性患者侵蚀性关节炎的比例显著升高(25.7%与4.6%,P<0.01)。结论 24.1%的SLE患者出现抗CCP抗体,抗CCP抗体的出现与SLE伴发关节炎和骨关节侵蚀性破坏密切相关。 Objective To invesigate the clinical significance of anti-cyclic citrullinated peptides antibodies(anti-CCP) in systemic lupus erythematosus(SLE) patients with arthritis,and to explore the association of anti-CCP with erosive arthritis and judge prognosis in SLE patients.Methods 145 SLE patients were examined for anti-CCP and IgM-RF with enzyme-linked immunosorbent assay method and rate turbidimetric method.Results The frequency of ant-CCP was 24.1% in this group of SLE patients.The frequency of arthritis was significantly higher in SLE patients with anti-CCP than without anti-CCP(77.1% VS 38.2%,P〈0.05).Anti-CCP antibodies were more frequently detected in SLE patients with arthritis than those without arthritis(39.1% VS 10.5%,P〈0.05).The frequency of RF-positive group with Anti-CCP than that without anti-CCP was(38.5% VS 24.4%,P〈0.05).When compared with anti-CCP negative patient,erosive arthritis occurred more often in anti-CCP positive patients than nagative anti-CCP patients(25.7% VS 4.6%,P〈0.001).Conclusion Anti-CCP antibodies have a prevalence in our group of SLE patients and its presence is closely associated with erosion of bone and joint destruction.
出处 《安徽医学》 2011年第9期1217-1220,共4页 Anhui Medical Journal
基金 国家自然科学基金(项目编号:81072462) 安徽省高校省级自然科学研究项目(项目编号:KJ2009B072) 安徽省自然科学基金(项目编号:090413253)
关键词 红斑狼疮 系统性 关节炎 抗环瓜氨酸肽抗体 Lupus erythematosus systemic Arthritis Anti-cyclic citrullinated peptides antibodies
  • 相关文献

参考文献12

  • 1Aletaha D,Neogi T,Silman AJ,et al.2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initiative.Ann Rheum Dis,2010,62 (9):1580-1588.
  • 2Hayashi N,Kumagai S.Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis Rinsho Byori.Article in Japanese,2010,58 (5):466-479.
  • 3Kakumanu P,Sobel ES,Narain S,et al.Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosivearthritis.J Rheumatol,2009,36(12):2682-2690.
  • 4Atzeni F,Sarzi-Puttini P,Lama N,et al.Anti-cyclic citrullinated peptide antibodies in primary sj(o)gren syndrome may be associated with non-erosive synovitis.Arthritis Res Ther,2008,10(3):R51.
  • 5Morita Y,Muro Y,Sugiura K,et al.Anti-cyclic citrullihated peptide antibody in systemic sclerosis.Clin Exp Rheumatol,2008,26 (4):542-547.
  • 6毛桐俊,徐亮.抗环瓜氨酸肽抗体与系统性红斑狼疮关节病变研究进展[J].安徽医学,2011,32(1):123-125. 被引量:1
  • 7Damián-Abrego GN,Cabiedes J,Cabral AR.Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.Lupus,2008,17 (4):300-304.
  • 8Chan MT,Owen P,Dunphy J,Bojatil R.Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class Ⅱ alleles in systemic lupus erythematosus.J Rheumato1,2008,35 (1):77-83.
  • 9赵义,李小霞,李林,李晶,李春,栗占国.抗环瓜氨酸肽抗体与系统性红斑狼疮关节炎的相关性研究[J].中华风湿病学杂志,2009,13(2):79-83. 被引量:9
  • 10Amezcua-Guerra LM,Márquez-Velasco R,Bojalil R.Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies.Inflamm Res,2008,57(12):555-557.

二级参考文献39

  • 1Cohen MG, Webb J. Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. Ann Rheum Dis, 1987, d-6: 853-858.
  • 2Fischman AS, Abeles M, Zanetti M, et al. The coexistence of rheumatoid arthritis and systemic lupus erythematosus: a case report and review of the literature. J Rheumatol, 1981, 8: 405-415.
  • 3Kroot EJ, de Jong BA, van Leeuwen MA, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum, 2000, 43: 1831-1835.
  • 4Bongi SM, Manetti R, Melchiorre D, et al. Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA. Autoimmunity, 2004. 37: 495-501.
  • 5Hoffman IE, Peene I, Cebecauer L, et al. Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus. Ann Rheum Dis, 2005, 64: 330-332.
  • 6Martinez JB, Valero JS, Bautista AJ, et al. Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol, 2007, 25: 47-53.
  • 7Chan MT, Owen P, Dunphy J, et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class Ⅱ alleles in systemic lupus erythematosus. J Rheumatol, 2008, 35: 77-83.
  • 8Vencovsky J, Machacek S, Sedova L, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis, 2003, 62: 427-430.
  • 9Nell VP, Machold KP, Stamm TA, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis, 2005, 64: 1731-1736.
  • 10Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med, 2007, 146: 797-808.

共引文献8

同被引文献66

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部